Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Peptide Synthesis Market Size Worth USD 954.3 Million in 2030 | Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

27 Feb, 2023, 16:30 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, Feb. 27, 2023 /PRNewswire/ -- The Peptide Synthesis Market size was valued at USD 506.2 Million in 2021 and is expected to register a CAGR of 7.2% during the forecast period, according to a report by Emergen Research. The market growth is primarily driven by the increasing demand for peptide therapeutics for the treatment of various diseases such as cancer, metabolic disorders, and infectious diseases. The use of peptides as diagnostic tools in various fields such as oncology, neurology, and cardiology is also driving the growth of the market.

Drivers:

The increasing incidence of chronic diseases such as cancer and diabetes is driving the demand for peptide therapeutics. According to the World Health Organization, cancer is one of the leading causes of death worldwide, accounting for approximately 9.6 million deaths in 2018. Peptide therapeutics have shown promising results in the treatment of cancer and are becoming an important part of the treatment regimen. The increasing demand for personalized medicine is also driving the growth of the market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1346

In addition, the development of new technologies for peptide synthesis is expected to drive the market growth during the forecast period. The use of microwave-assisted solid-phase peptide synthesis and flow chemistry has significantly improved the efficiency of peptide synthesis. The use of these technologies has led to a reduction in the time and cost involved in peptide synthesis, thereby driving the growth of the market.

Restraints:

The high cost associated with peptide synthesis is a major restraint for the market. The cost of raw materials, equipment, and labor is high, which makes peptide synthesis expensive. In addition, the complexity of peptide synthesis and the need for highly skilled personnel is a major challenge for the market.

Another major challenge for the market is the lack of regulatory guidelines for peptide therapeutics. The lack of clear guidelines and regulations for the development and commercialization of peptide therapeutics is hindering the growth of the market.

Growth Projections:

The peptide synthesis market is expected to register a CAGR of 7.2 % over the forecast period and revenue is projected to increase from USD 506.2 Million in 2021 to USD 954.3 Million in 2030. The increasing demand for peptide therapeutics for the treatment of chronic diseases such as cancer and diabetes is expected to drive the growth of the market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1346

Current Trends and Innovations:

One of the key trends in the peptide synthesis market is the development of cell-penetrating peptides (CPPs). CPPs are short peptides that can penetrate cell membranes and deliver drugs or other molecules into cells. CPPs have shown promising results in the treatment of various diseases such as cancer and neurodegenerative diseases.

Another trend in the market is the use of peptides as diagnostic tools. Peptides can be used as biomarkers for the early detection of diseases such as cancer and Alzheimer's disease. The development of new technologies for peptide synthesis is also driving innovation in the market.

Strategic Initiatives:

Key players in the market include Bachem Holding AG, CEM Corporation, AAPPTec LLC, Genscript Biotech Corporation, Advanced ChemTech Inc., Merck KGaA, Novo Nordisk A/S, Thermo Fisher Scientific Inc., and AnaSpec Inc. These companies are focusing on strategic initiatives such as collaborations, partnerships, and acquisitions to expand their market presence.

For instance, in April 2022, Bachem Holding AG announced the acquisition of Synprosis, a specialist in the development of synthetic peptides and peptidomimetics for drug discovery. The acquisition is expected to strengthen Bachem's position in the peptide synthesis market.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/peptide-synthesis-market

Scope of Research

Report Details

Outcome

Market size in 2021

USD 506.2 Million

CAGR (2022–2030)

7.2 %

Revenue forecast to 2030

USD 954.30 Million

Base year for estimation

2021

Historical data

2019–2020

Forecast period

2022–2030

Quantitative units

Revenue in USD Billion and CAGR in % from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product type, technology, end-use, and region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA

Key companies profiled

GenScript, ThermoFisher Scientific, Merck KGaA, Bachem, Kaneka Corporation, Biotage, Syngene International Limited, Mesa Labs, Inc., CEM Corporation, ProteoGenix

Customization scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1346

Emergen Research has segmented the global peptide synthesis market on the basis of product type, technology, end-use, and region:

  • Product Type Outlook (Revenue, USD Million; 2019-2030)
    • Reagents
    • Equipment
  • Technology Outlook (Revenue, USD Million; 2019-2030)
    • Solid-phase peptide synthesis
    • Liquid-phase peptide synthesis
    • Hybrid & recombinant technology
  • End-Use Outlook (Revenue, USD Million; 2019-2030)
    • Pharmaceutical & Biotechnology Companies
    • Contract Development & Manufacturing Organization and Contract Research Organization
    • Academic & Research Institutes
    • Others
  • Regional Outlook (Revenue, USD Million; 2019-2030)
    • North America
      • U.S.
      • Canada
      • Mexico
  •  
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Benelux
      • Rest of Europe
  •  
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of APAC
  •  
    • Latin America
      • Brazil
      • Rest of LATAM
  •  
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Turkey
      • Rest of MEA

Latest Research Reports Published by Emergen Research:

Network Engineering Services Market, By Service Type (Network Assessment and Network Deployment), By Organization Size (Small & Medium Enterprises and Large Enterprises) and By End-Use (BFSI Telecom and Healthcare), By Region Forecast to 2030

Operational Technology Market, By Component (Field Instruments and Control System), By Networking Technology (Wired, and Wireless), By Industry (Process Industry, Discrete Industry, and Others), and By Region Forecast to 2030

Medical Devices Batteries Market, by Product Type (Implantable and Non-Implantable Batteries), by Battery Type, by End User, and By Region Forecast to 2030

Clustered Regularly Interspaced Short Palindromic Repeats Technology Devices Market, By Product & Service (Kits & Enzymes, Libraries, Cell Line Engineering, and gRNA Design), By Application(Biomedical and Agricultural), By End-Use, and By Region Forecast to 2030

Pediatric Oncology Market, By Indication (Leukemia and Neuroblastoma), By Treatment (Chemotherapy and Radiotherapy), By End-Use (Hospitals and Cancer & Radiation Therapy Centers), and By Region Forecast to 2030

Cardiogenic Shock Market, By Treatment Type (Drugs, Devices, and In-Vitro Test Kits), By End-Use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region Forecast to 2030

Subscriber Identity Module Cards Market, By Type, By Application (Mobile Phone, Tablet, Wearable Device, and Others), By SIM Memory, and By Region Forecast to 2030

Smoke Detector Market By Power Source (Battery-powered and Hardwired), By Product Type (Photoelectric Smoke Detectors, Ionization Smoke Detectors, and Others), By Service, By End-use, and By Region Forecast to 2030

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee 
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com  
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com  
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations  
Visit for More Insights: https://www.emergenresearch.com/insights  
Explore Our Custom Intelligence services | Growth Consulting Services  
Read our Press Release @ https://www.emergenresearch.com/press-release/global-peptide-synthesis-market  
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.